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ABSTRACT
In one of the ®rst steps of prokaryotic ribosome
assembly, the ribosomal protein S15 binds to a
three-way junction in the central domain of the 16S
rRNA. Binding causes a conformational change that
is required for subsequent binding events. Using a
novel ¯uorescence resonance energy transfer assay
with three ¯uorophores, two on the RNA and one on
the S15 protein, small-molecule libraries can be
screened for potential inhibitors of this initial step
in ribosome assembly. The employment of three
¯uorophores allows both the conformational
change of the RNA and the binding of S15 to be
monitored in a single assay.
INTRODUCTION
During the assembly of prokaryotic 30S ribosomal subunits,
the small subunit proteins bind to the 16S rRNA in a
hierarchical manner, as described by the assembly map
developed by Nomura (1,2). The small subunit proteins are
grouped into primary, secondary and tertiary binding proteins,
depending on the requirements for prior protein binding. S15
is a primary binding ribosomal protein that binds independ-
ently to a three-way junction (3WJ) in the central domain of
the 16S rRNA in the early stages of 30S subunit assembly.
Binding of S15 induces a conformational change in the 3WJ
formed by helices 20, 21 and 22 which leads to coaxial
stacking of helices 21 and 22, while helix 20 forms a 60° angle
with helix 22 (3). The stabilization of this conformation by
S15 is a prerequisite for subsequent binding events during the
assembly of 30S subunits, and thus is a key step in the
formation of functional 70S ribosomes.
The sequence of this region of the 16S rRNA differs from
the homologous sequence in human 80S ribosomes; therefore
the S15 binding site is a potential target for selective blocking
of prokaryotic ribosome assembly. Inhibition of ribosome
assembly could be achieved by small-molecule compounds
that bind to the 3WJ and inhibit either the conformational
change itself or S15 binding, which might result in antibiotic
activity.
In order to identify lead compounds for potential anti-
biotics, high-throughput methods are required to screen large
diverse sets of compounds ef®ciently. Fluorescence assays are
particularly well suited for high-throughput screening because
they are sensitive, can be automated and can be rapidly
performed in small volumes and large format using microtiter
plates.
Here we describe a three-¯uorophore ¯uorescence reson-
ance energy transfer (FRET) assay that allows for screening of
small-molecule libraries for potential inhibitors of ribosome
assembly. As a model system, a minimal 3WJ containing all
determinants for binding of S15 is labeled with two
¯uorophores (donor and acceptor 1), and a third ¯uorophore
(acceptor 2) is attached to S15. The three ¯uorophores are
placed such that the conformational change of the 16S rRNA
central domain 3WJ and the binding of S15 can be monitored
simultaneously in one screen. We show that this FRET assay
reliably identi®es compounds that bind to the junction and
affect the conformation, and has the potential to identify
compounds that interfere with S15 binding. Owing to the high
sensitivity and the small amounts of material needed, this
assay can be performed in 384-well microtiter plates and thus
can be readily adapted to high-throughput screening for novel
inhibitors of 30S assembly.
MATERIALS AND METHODS
RNA constructs
The 16S rRNA 3WJ was formed from the three strands (Fl)-
22-20 [5¢-(¯uorescein)-UGG UCU GGC CUG CAC CUG
ACG CCA GCU CGC ACC A-3¢], (TMR)-20-21 [5¢-(tetra-
methylrhodamine)-UGG UGC GAG CUG GCG GUC UUC
CA-3¢], and 21-22 (5¢-UGG AAG ACU UGA GGG CAG
GAG AGG ACC A-3¢) (Dharmacon Research, La Fayette,
CO). RNA samples were annealed by mixing 5 mM of each
strand in 100 mM sodium phosphate pH 7.2, 100 mM KCl,
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heating to 95°C for 2 min and subsequent cooling to 35°C in
30 min. For the assay, this stock solution was diluted 25-fold
with 50 mM Tris±HCl pH 7.5 and 0.5% Tween 20.
Preparation of S15-R78C and labeling with Texas red
The R78C mutation was introduced into the S15 gene using
the QuickChange kit (Stratagene). The gene for S15-R78C
was cloned into vector pJM109, and the S15 protein, fused to
an N-terminal His-tag and a factor Xa cleavage site, was
overproduced in Escherichia coli BL21(DE3). Cells were
grown in LB medium (50 mg ml±1 ampicillin) to an OD600 of
0.6, and protein production was induced by adding 1 mM
isopropyl-b-D-thiogalactoside (IPTG). The cells were har-
vested 4 h after induction. The cell pellet (8 g wet cells) was
suspended in 80 ml lysis buffer [50 mM Tris±HCl, pH 8.0,
100 mM KCl, 1 mM EDTA, 0.1 mM PMSF, 1 mM
b-mercaptoethanol (b-ME)]. Cells were lysed with lysozyme
(1 mg ml±1) in the presence of 1 mg ml±1 sodium
desoxycholate [45 min, room temperature (RT)]. DNA was
hydrolyzed by adding DNase I (0.5 U ml±1) and MgCl2
(2 mM). To solubilize the protein, guanidinium chloride
(GdmCl) was added to 6 M, and the solution was stirred for 1 h
at RT. Cell debris was removed via centrifugation (15 000 g)
and 10 ml Ni2+-nitrilotriacetate (NTA) agarose was added to
the supernatant. The Ni2+-NTA resin was poured into a
column and washed with 100 ml of 100 mM NaH2PO4, 10 mM
Tris±HCl pH 8.0 and 6 M GdmCl. The S15 protein was eluted
in 20 ml 6 M GdmCl in 0.2 M AcOH, dialyzed twice against
2% AcOH and lyophilized. The lyophilized protein was
dissolved in 4 M urea and applied to a C18 column
equilibrated in 5% MeCN and 0.1% TFA. The column was
eluted with a 5±50% MeCN gradient in 0.1% tri¯uoroacetic
acid (TFA). The S15-containing fractions were pooled and
lyophilized. The lyophilized protein was redissolved in
100 mM Tris±HCl pH 7.5, 6 M GdmCl and 5 mM EDTA to
a ®nal concentration of 1 mM. Disul®des were reduced by
incubation with a 50-fold excess of dithiothreitol (DTT) at
37°C for 1 h. The excess of DTT was removed by size
exclusion chromatography (G25 NAP-10) and the protein
solution was diluted to a concentration of 100 mM.
Fluorescence labeling was performed at 37°C for 2 h using a
10-fold excess of Texas red (TR) maleimide. The excess of
unreacted dye was removed by incubating the reaction mixture
with Ni2+-NTA agarose for 30 min. After washing with
100 mM NaH2PO4, 10 mM Tris±HCl pH 8.0 and 6 M GdmCl,
the S15 protein was eluted with 6 M GdmCl and 2% AcOH.
The labeled S15 was separated from unlabeled protein by a
second C18 reversed phase chromatography step, and colored
fractions were pooled and lyophilized. To remove the His-tag,
the lyophilized protein was dissolved in cleavage buffer
(20 mM Tris±HCl pH 8.0, 100 mM NaCl, 2 mM CaCl2) and
incubated with 2 ml (0.04 U) factor Xa per milligram of protein
at room temperature for 1 h. The cleavage reaction was
stopped by addition of urea (8 M) and the solution was
incubated with Ni2+-NTA to remove uncleaved protein. The
supernatant was applied to a C18 column, which was
developed as described above. Fractions containing
S15-R78C labeled with TR (S15-TR) were pooled, dialyzed
against H2O and lyophilized in aliquots.
Fluorescence measurements
Fluorescence measurements were performed in a Spectramax
Gemini ¯uorescence microplate reader using 384-well plates.
The well volume was 20 ml. For the assay, the ®nal
concentrations were as follows: 20 nM 16S rRNA junction,
50±80 nM S15-TR and 1 or 10 mM library compound in 50 mM
Tris±HCl pH 7.5 and 0.5% Tween 20. Fluorescein (Fl) was
excited at 485 nm (bandwidth 9 nm), and emissions of Fl,
tetramethylrhodamine (TMR) and TR were recorded at 528,
581 and 614 nm, respectively, (bandwidths 9 nm) using 515-,
570- and 610-nm cut-off ®lters. Spectra were recorded with
2 nm resolution from 515 to 650 nm using a 515-nm cut-off
®lter.
RESULTS
Design of the model system: rationale for choice of
¯uorophores and attachment sites
The conformational change of the 16S rRNA 3WJ leads to
stacking of helices 22 and 21, and a decrease in the end-to-end
distance of helices 20 and 22 from 70 to 40 AÊ (Fig. 1). To
exploit the distance dependence of the FRET ef®ciency as a
probe for the conformational change, donor and acceptor 1
¯uorophores were therefore placed on arms 20 and 22. Upon
excitation of the donor, ¯uorescence emission would be
expected mainly from the donor due to the long inter¯uoro-
phore distance and the resulting low FRET ef®ciency. In the
folded junction, the reduced inter¯uorophore distance leads to
an increase in FRET ef®ciency, and upon excitation of the
donor, emission from acceptor 1 would be expected. FRET has
already been used to detect the Mg2+- and S15-induced
conformational change on a single molecule using Cy3
(donor) and Cy5 (acceptor) (4,5).
To independently monitor the binding of S15 to the 3WJ, an
additional ¯uorescent probe (acceptor 2) was attached to the
S15 protein. Using the crystal structure of the 16S rRNA-
central domain.S15.S6.S18 particle (6) as a guide, residue 78
of S15 was selected for introduction of a cysteine for
¯uorophore attachment. As the side chain of residue 78 points
away from the RNA into solution, modi®cations at this site
should not interfere with RNA binding. The distances between
position 78 and the ends of helical arms 20 and 22 are 56 and
37 AÊ , respectively, which allows for ef®cient FRET from the
donor and acceptor 1 ¯uorophores to acceptor 2. Fl, TMR and
TR were chosen as donor, acceptor 1 and acceptor 2. Fl
absorbs at 495 nm (lmax), the emission maximum is at 530 nm
(lmax). The TMR absorption (lmax = 546 nm) overlaps with
the Fl emission, and the TMR emission (lmax = 581 nm)
overlaps with the TR absorption (lmax = 582 nm), ful®lling the
requirements for an energy relay from donor to acceptor 1 to
acceptor 2. Direct transfer from Fl to TR is also possible. The
FoÈrster distances R0 for the donor±acceptor pairs are 54 AÊ
(Fl±TMR), 54 AÊ (Fl±TR) and 62 AÊ (TMR±TR), respectively.
Therefore one would expect mainly Fl emission in the
unfolded junction, mainly TMR emission in the folded
junction and mainly TR emission once the S15 protein is
bound (Fig. 1).
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Three-¯uorophore system: attachment of ¯uorophores
does not interfere with RNA folding and S15 complex
formation
As a control to establish the model system, the doubly labeled
junction was titrated with Mg2+ and S15. Folding of the
junction and S15 binding were measured via FRET between Fl
and TMR (Fig. 2). All experiments were performed in a
microplate reader using 384-well plates and volumes of 20 ml
per well. The Kd values determined for Mg2+ and S15
complexes were 77 mM and 50 nM, respectively, which is
similar to those for binding of Mg2+ and wild-type S15 to the
Figure 1. Folding equilibrium of the central domain 3WJ and ¯uorophore attachment for the ¯uorescence assay. Shown is a schematic depiction of the central
domain 3WJ of the 16S rRNA comprising helices 20, 21 and 22 (black). In the absence of Mg2+ and S15, the junction is extended (left). Both Mg2+ and S15
induce the formation of a compact structure [folded junction (middle)], in which the helical arms 20 and 22 form a 60° angle and helices 22 and 21 stack
coaxially. S15 binds to the junction and stabilizes the folded form (right). The ¯uorophores used in the FRET assay are indicated in green (donor, Fl, helix
22), orange (TMR, acceptor 1, helix 20) and red (TR, acceptor 2, Cys78 of S15). The black arrow indicates the excitation of the donor, and the bold arrows
indicate which ¯uorophore mainly contributes to the emission spectra in each species.
Figure 2. Mg2+ and S15 titrations. (A and B) Titration of the Fl/TMR 3WJ (20 nM) with Mg2+ and S15. Folding of the junction is monitored via the ratio of
Fl/TMR emission intensities. (C and D) Titration of the Fl and Fl/TMR 3WJ with S15-TR. S15-TR binding is followed via the ratio of TMR/TR emission
intensities. Non-linear least-squares analysis yields Kd values of 77 mM (Mg2+ binding) and 50 nM (S15 binding). The binding of S15-TR to the ¯uorescently
labeled junction is characterized by Kd values of 17 nM (Fl junction) and 27 nM (Fl/TMR junction), con®rming that the system is not compromised by
¯uorophore attachment.
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natural junction [Kd(Mg2+) = 100 mM; Kd(S15) = 10±30 nM].
These results con®rm that neither Mg2+-induced folding nor
binding of S15 are hampered by the attached ¯uorophores.
Similar ¯uorescence changes have been observed in single-
molecule FRET experiments using a Cy3/Cy5-labelled junc-
tion (4,5).
To con®rm that S15-TR maintains wild-type-like binding to
the 3WJ, the Fl-only and the Fl/TMR-labeled junctions were
titrated with S15-TR. Kd values of 17 nM (Fl only) and 27 nM
(Fl/TMR) were obtained. Comparison with binding of wild-
type S15 (Kd = 50 nM) suggests that the presence of the TR
¯uorophore on S15 does not affect the integrity of the S15
protein or its ability to bind RNA.
Proof of principle I: distinction of three different species
from ¯uorescence properties
To monitor the conformational change of the 16S rRNA 3WJ
and the binding of S15 in one assay, it is required that the three
species, (i) free RNA, extended, (ii) free RNA, folded, and
(iii) S15-bound RNA, can be easily distinguished by their
¯uorescence properties. Fluorescence emission spectra of the
extended junction (no Mg2+), the folded junction (10 mM
Mg2+) and the S15-TR-bound junction (Fig. 3) exhibit
characteristic ¯uorescence maxima at the emission wave-
lengths of the three dyes. The spectrum of the unfolded
junction is dominated by the emission from the Fl (528 nm),
while in the folded junction the emissions at the Fl and TMR
emission wavelengths (528 and 581 nm) are nearly equal. The
¯uorescence emission of the S15-TR-RNA complex is
dominated by TR (614 nm), indicating that, once the protein
is bound, FRET from Fl (and presumably also from TMR) to
TR is almost complete. Thus the predominant species can be
extracted from the shape of spectra and the relative emission
intensities at the emission maxima of the three dyes.
Proof of principle II: competition with an excess
unlabeled RNA junction displaces the Fl/TMR junction
from S15-TR
To demonstrate that, in principle, addition of an inhibitor for
S15 binding can be detected with this FRET assay, binding of
S15-TR to the Fl/TMR-labeled RNA junction was monitored
in the presence and absence of an excess of unlabeled junction.
The emission spectra (Fig. 4) in the absence of competitor
shows the characteristic emission maxima of the S15-rRNA
complex at 614 nm (TR). In the presence of a 50-fold excess of
unlabeled RNA, however, the emission maxima are at 528 and
581 nm, indicating that the Fl/TMR-labeled RNA is not bound
to S15-TR. This con®rms that it is feasible to identify
compounds that interfere with binding of S15-TR to the
Fl/TMR-labeled RNA junction using this FRET assay. The
binding of S15-TR is monitored best via the ratio of emission
intensities at 581 and 614 nm, where the folded and unfolded
RNA junction provides a clearly distinct signal (F581/F614 =
2.5±3 without protein bound; F581/F614 = 0.7 with protein
bound). The characteristic ratios of emission intensities for the
three species are summarized in Table 1.
Binding of aminoglycosides
Aminoglycoside antibiotics are a diverse family of com-
pounds that have been shown to speci®cally target different
RNAs (7±15). They also interact with RNA non-speci®cally
due to their multiple positive charges at neutral pH. To test the
¯uorescence assay with compounds known to interact with
RNA, the Fl/TMR 3WJ was titrated with gentamicin,
hygromycin, kanamycin B, neomycin, paromomycin, strepto-
mycin and tobramycin (Figs 5A and 6A). All of the
Figure 3. Fluorescence emission spectra of the unfolded Fl/TMR junction,
the folded junction and the junction in complex with S15-TR. The donor
¯uorophore was excited at 485 nm and the ¯uorescence emission spectra
were recorded from 515 to 650 nm (9 nm bandwidth). Continuous line,
emission spectrum for the unfolded junction (in 50 mM Tris±HCl pH 7.5
and 0.5% Tween 20); dashed line, folded junction (in 50 mM Tris±HCl pH
7.5, 10 mM MgCl2 and 0.5% Tween 20); dotted line, junction bound to
S15-TR (in 50 mM Tris±HCl pH 7.5, 0.5% Tween 20 and 50 nM S15-TR).
The RNA concentration is 20 nM. Each species has a characteristic emis-
sion maximum, which means that in reverse from the ¯uorescence emission
intensities at 528 nm (Fl), 581 nm (TMR) and 614 nm (TR), the predomin-
ant species can be deduced. The conformational change can be monitored
via the ratio of emission intensities at 528 and 581 nm (Fl/TMR), and
protein binding can be monitored via the ratio of emission intensities at 581
and 614 nm (TMR/TR).
Figure 4. Fluorescence spectra for competition. Spectra were measured as
described for Figure 3. Dashed line, folded junction (in 50 mM Tris±HCl,
pH 7.5, 10 mM MgCl2 and 0.5% Tween 20); dotted line, junction bound to
S15-TR (in 50 mM Tris±HCl pH 7.5, 0.5% Tween 20 and 50 nM S15-TR);
dashed-dotted line, junction in the presence of 50 nM S15-TR after addition
of a 50-fold excess of unlabelled competitor RNA. The RNA concentration
is 20 nM. Upon addition of an excess of unlabeled RNA, the Fl/TMR
junction is displaced from S15-TR, and the spectra overlays that of the free
folded junction reasonably well. This con®rms that addition of a compound
that interferes with binding of S15-TR to the Fl/TMR junction can be
detected from changes in FRET to S15-TR via an increase in the ratio of
the emission intensities at 581 and 614 nm (TMR/TR).
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aminoglycosides tested induce folding of the junction.
Presumably, they bind to the RNA and act in a similar
manner to the Mg2+ ions that stabilize the compact folded form
by electrostatic screening of negatively charged phosphates in
the junction region. Titrations of the Fl/TMR junction with
S15-TR in the presence of 5 mM concentrations of
aminoglycosides do not show any inhibition of S15 binding
to the junction, however (Fig. 5B), indicating that the S15
binding site is not blocked by these aminoglycosides.
Assay with RNA only
Aminoglycosides have been used as lead compounds to
optimize binding and inhibition properties. We constructed a
small library of synthetic neamine-based aminoglycoside
analogs comprising neamine dimers connected by various
linkers (compounds 1±12), neamine carrying different sub-
stituents in the 5-O position (compounds 13±31), ribostamycin
substituted at the ribose (compound 32) and substituted amino
sugars (compounds 33 and 34) (Fig. 6) (8,9). Most of
compounds 1±12 inhibit translation by binding to the A site
of prokaryotic rRNA at micromolar concentrations. In
addition, some of them are poor substrates for the aminoglyco-
side-modifying enzymes that are the major cause of
aminoglycoside resistance (9). Most of compounds 13±31
bind to the oncogenic Bcr-Abl mRNA (8).
To investigate the effect of the aminoglycoside library
compounds on the folding of the junction, the ¯uorescence
emission intensities at 528 and 581 nm of the 20 nM Fl/TMR
junction in 50 mM Tris±HCl pH 7.5 and 0.5% Tween 20 were
measured in the presence of 1 and 10 mM concentrations of
compounds 1±34 (Fig. 7A). The ratio of the emission
intensities contains information on the folding state of the
junction: a value of 3±3.5 (F528/F581) is indicative of an
unfolded RNA junction, while a low value of ~1 is charac-
teristic of the folded junction (Table 1). The ratios observed in
the presence of the library compounds cover the whole range
of possible values, indicating that most of the compounds
favor junction folding but with different ef®ciencies.
According to their effect, the compounds can be assigned to
three different classes: (i) no effect at 1 or 10 mM compound
concentration, (ii) binding that titrates in the concentration
range 1±10 mM and (iii) binding that is already complete at
1 mM compound concentration with no change at 10 mM.
Titrations of the Fl/TMR-labeled junction with compounds 1,
2, 11, 14, 20 and 33, selected from each class, were performed
to test whether differences in assay results re¯ect differences
in binding af®nity (Fig. 7B). While compounds 2 and 33 show
no effect in the assay at either concentration, indicating that
they bind to the junction with Kd » 10 mM, the effects of
compounds 1 and 11 are (almost) complete at 1 mM ligand
concentration, indicating that the Kd in these cases is <1 mM.
Compounds 14 and 20 show a small effect at a concentration
of 1 mM, and increased effects at 10 mM, suggesting that the
Kd is in the range 1±10 mM. Consistently, non-linear least-
squares analysis of the titration curves assuming a simple 1:1
binding mode yields Kd values of 0.24 6 0.05 and 0.20 6 0.05
mM for compounds 1 and 11, respectively, and Kd values of
1.2 6 0.4 and 0.8 6 0.2 mM for compounds 14 and 20,
respectively. For compounds 2 and 33, no changes are
observed, consistent with Kd >> 10 mM. These results con®rm
that in the range of concentrations used in the assay,
differences in Kd values of a factor of 5 can be easily detected.
According to the signals obtained at different concentrations,
the assay is sensitive towards substances that form complexes
with the RNA in the Kd range 0.1±5 mM.
Assay in the presence of S15
The same library was screened to look for inhibitors of S15
binding. The ¯uorescence emission intensities at 581 and
Figure 5. Interactions of the Fl/TMR junction with aminoglycosides.
(A) The Fl/TMR 3WJ (20 nM, black) was titrated with gentamicin (red),
hygromycin (green), kanamycin (blue), neomycin (cyan), paromomycin
(magenta), streptomycin (dark yellow) and tobramycin (brown). The ratio of
Fl/TMR emission is monitored as a probe for junction folding. (B) Titration
of the Fl/TMR 3WJ (20 nM, black) with S15-TR in the presence of 5 mM
aminoglycoside. The color scheme is the same as in (A). The ratio of TMR/
TR emission is monitored as a probe for S15 binding. While all amino-
glycosides appear to stabilize the folded conformer of the junction with
different concentration dependence, none of them inhibits S15 binding.
Table 1. Characteristic emission ratios for unfolded, folded and S15-bound
16S rRNA 3WJ
F528/F581 F528/614 F581/F614
Unfolded RNA 2.3 6.3 2.8
Folded RNA 0.7 2.2 3.2
S15-bound RNA 2.1 1.6 0.8
Ratios are calculated from spectra shown in Figure 3. The indicators for
RNA folding (F528/F581) and for S15 binding (F581/F614) are highlighted
in bold.
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614 nm of 20 nM Fl/TMR junction in 50 mM Tris±HCl pH 7.5
and 0.5% Tween 20 were measured in the presence of 1 and 10
mM concentrations of compounds 1±34 and 50 nM S15-TR
(Fig. 8). As demonstrated by the spectra of free (unfolded or
folded) and S15-TR-bound Fl/TMR junctions (Figs 2 and 3),
the ratio of the emission intensities at 581 nm (TMR) and 614
nm (TR) is indicative of S15 binding: a high value of 3±4 is
characteristic of free RNA and S15, while a low value of ~0.7
is characteristic of S15 bound to the RNA. None of the
compounds result in a high ¯uorescence ratio, suggesting that
even though most of the library compounds promote folding of
the RNA junction, none affects S15 binding to the junction.
DISCUSSION
We have shown that a three-¯uorophore assay with one
¯uorescence donor and two acceptors can monitor two
different molecular events during ribosome assembly simul-
taneously. By placing the donor and acceptor 1 on an RNA
molecule and acceptor 2 on a protein binding to this RNA,
both a conformational change within the RNA and the binding
of the protein to the RNA can be followed. Even though
the introduction of three bulky ¯uorophores is a major
modi®cation of the protein±RNA complex, no deleterious
effects on the conformational change itself or on S15 binding
were detected. The ratiometric approach allows for unam-
biguous assignment of the three species occurring: unfolded
RNA, folded RNA and folded RNA bound to protein. This
example shows that, with careful design, ¯uorescence
methods are applicable to complex molecular events.
Importance of RNA as a target
RNA is an important therapeutic target due to its key function
in many biological processes such as protein biosynthesis,
splicing and viral replication. Various RNA aptamer structures
have demonstrated that RNA can de®ne speci®c binding sites
for small molecules such as FMN (16,17), cAMP and cGMP
(18,19), theophylline (17,20), aminoglycosides (21,22) and
¯uorophores (23) [reviewed in (24,25)]. Conformational
changes in RNA are ubiquitous events that are often strictly
regulated and constitute crucial steps in RNA folding.
Therefore, ®nding inhibitors for conformational changes is
an approach easily adaptable to other RNA targets. The
universal nature of RNA conformational changes, which
inevitably result in intramolecular distance changes, leads to a
broad application range of FRET assays. As most prokaryotic
sequences differ from the corresponding eukaryotic se-
quences, they provide speci®c targets to interfere with
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prokaryotic life without exerting side-effects on the eukaryotic
host.
Aminoglycosides
To identify a lead compound for inhibitors of ribosome
assembly using our model system consisting of the Bacillus
stearothermophilus ribosomal central domain 3WJ and S15,
the particular compound needs to show high-af®nity binding
to the RNA and overlap of its binding site with S15 binding.
Aminoglycosides are positively charged amino sugars that
interact both speci®cally and non-speci®cally with different
RNA molecules with af®nities in the low micromolar range
(7±11). In addition to the decoding region of prokaryotic
rRNA (12), targets for aminoglycoside binding include the
group I intron (14), hammerhead ribozymes (13) and the
transcriptional activator region RRE from HIV (15). The
number of different targets for aminoglycosides suggests that
many structural solutions exist that provide RNA binding
interfaces for these antibiotics. In general, aminoglycosides
bind to the major groove of an irregular helix (26).
Aminoglycosides are relatively ¯exible structures that can
be accommodated in a binding pocket. Two types of binding
site have been proposed: asymmetric internal loops and metal
ion binding sites (26). Altogether, they seemed to be well
suited as test compounds for optimization of assay conditions.
All seven aminoglycosides tested favor folding of the 16S
rRNA 3WJ, presumably by screening a high negative charge
density in the compact folded structure. The binding af®nities
decrease in the following order: gentamicin > tobramycin >
neomycin = kanamycin > paromomicin = streptomycin >
hygromycin. However, none of these compounds competes for
S15 binding with the RNA junction at the concentrations
tested. The reason could be non-overlapping binding sites for
S15 and the aminoglycosides, or low binding af®nities
compared with the tight binding of S15 to its RNA target.
Binding of library compounds to the 3WJ
Based on aminoglycoside structures, a library was constructed
that exploits the potential of this class of antibiotics for
speci®c binding in an effort to achieve tighter/speci®c binding
by introducing various additional groups (Fig. 6). The
modi®cations could also provide compounds better suited
for medical applications, such as compounds less prone to
resistance or with fewer side-effects.
In summary, the library compounds could be grouped into
three different classes: (i) no effect, (ii) intermediate favorable
effect and (iii) strong favorable effect on folding of the central
domain 3WJ. None of the compounds showed an inhibitory
effect on S15 binding, however. This illustrates that the mere
selection for binding to the junction in the absence of S15 does
not necessarily identify binders that are able to compete with
S15 binding. Therefore the three-¯uorophore assay that
Figure 6. Structures of aminoglycosides and library compounds. (A) Structural formulae of gentamicin, hygromycin, kanamycin, neomycin, paromomycin,
streptomycin and tobramycin. (B) Structural formulae of library compounds 1, 2, 11, 14, 20 and 33. The neamine moiety is attached to the linkers at the
5-O position.
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monitors the effect on two molecular events is able to identify
competitive binders that may serve as lead compounds.
Library compounds 2 (a neamine dimer) and 33 (an amino
sugar derivative) had no effect on junction folding. In contrast
to the observations with the S15 binding site, compound 2 is
an inhibitor of translation, ef®cient at low micromolar
concentrations (9). This difference indicates that compound
2 does not exert its inhibitory effect on translation via the S15
binding site, nor can the potential of a compound as an
inhibitor be judged from its effect on different, but chemically
similar, targets. Compounds 1 and 11, both neamine dimers,
showed an intermediate effect on folding of the central domain
3WJ. Compounds 1 and 2 have a similar effect on in vitro
translation and similar antibiotic activity (9), yet they act
completely differently on the S15 binding site as a target.
Compound 11 contains two stereocenters (R,R). Interestingly,
the (S,S) stereoisomer (compound 7) binds with lower af®nity
to the junction, indicating that some speci®city can be gained
from stereochemistry. Compounds 14 and 20, both intermedi-
ate binders to the S15 binding site, are neamines carrying
different substituents. While they have similar effects on the
S15 binding site, compound 20 shows 5-fold tighter binding to
the oncogenic Brc-Abl mRNA (8). Altogether it is very clear
that good binders for one RNA target are not necessarily
similarly effective for another RNA target. This low predict-
ability renders an ef®cient high-throughput assay even more
important for screening a wide variety of compounds.
Potential of the assay
Fluorescence enables rapid screening of large numbers of
compounds. Less than 1 nmol of RNA is needed to screen
1000 compounds at two different concentrations in our assay.
Naturally, the less substance that is required, the stronger the
interaction studied. To achieve high-throughput capability, the
substance requirements can be lowered even further if
¯uorophores with higher extinction coef®cients and quantum
yields are used. Site-speci®c introduction of ¯uorescent
groups into RNA is possible via standard procedures (27).
Owing to the large linear range of our ¯uorescence assay, it
provides a large working range of ¯uorophore concentrations
and is adaptable to RNA±protein interactions with different
af®nities. The ratiometric approach leads to a robustness of the
assay. However, inconsistencies may occur for strongly
absorbing compounds or compounds with high auto¯uores-
cence. Once an effective compound has been identi®ed for a
speci®c target, the assay can be easily adapted to counter-
screening to determine the target speci®city of potential lead
compounds.
Conclusions
We have shown that three ¯uorescence values are suf®cient to
determine the effect of a potential inhibitor on two different
molecular events. We can independently monitor an RNA
Figure 7. FRET assay of compounds 1±34 with the RNA junction.
(A) Fl/TMR emission of 20 nM Fl/TMR junction in the presence of 1 and
10 mM concentrations of compounds 1±34. The lines indicate values for ex-
tended and folded junctions as determined in a control experiment. Except
for compounds 2 and 33, all compounds favor folding of the junction to
different extents. Three classes of compound can be distinguished: (1) the
compound shows no effect at 1 or 10 mM; (2) the effect titrates in the
concentration range 1±10 mM; (3) the effect is already complete at 1 mM
with no further change at 10 mM. (B) Titration curves of the junction and
selected compounds: 1 (black), 2 (red), 11 (green), 14 (blue), 20 (cyan) and
33 (magenta). Twenty nanomolar Fl/TMR junction were titrated with com-
pounds 2 and 33 (class 1), 14 and 20 (class 2) and 1 and 11 (class 3).
Consistent with the assay results, compounds 2 and 33 do not show binding
in this concentration range, and compounds 1 and 11 already reach
saturation at concentrations <1 mM. Non-linear least-squares analysis of the
titration curves according to a simple 1:1 binding model yields Kd values
of 0.24 6 0.05 mM (compound 1), 0.20 6 0.05 mM (compound 11), 1.2 6
0.4 mM (compound 14) and 0.8 6 0.2 mM (compound 20). These results are
in good agreement with the estimates obtained from two concentrations in
the assay.
Figure 8. FRET assay in the presence of S15-TR. TMR/TR emission of the
Fl/TMR junction (20 nM) in the presence of 50 nM S15-TR and 1 and
10 mM concentrations of compounds 1±34. The lines indicate values for
bound and free junction as determined in a control experiment. None of the
compounds in this small library interferes with S15 binding to the 16S
rRNA 3WJ.
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folding step and a protein binding step in a single assay.
Application of this assay in high-throughput mode with a large
compound library offers the opportunity to identify small-
molecule inhibitors of ribosome assembly.
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